Molecular medicine

Molecular medicine – or personalised medicine, still called precision medicine, – is based on a new approach to diagnosis, known as molecular diagnosis, which depends on analysis of the tumour genome. According to the results of this analysis, targeted drugs tailored to the genetic profile are tried. The objective is to be able to offer each patient drugs which are specifically targeted to the genetic profile of the tumour.     

General Secretariat For Research

International Scientific Board

Gustave Roussy has renewed its Scientific Board in 2021, as well as the terms of its operation.

Research Directorate

Gustave Roussy brings together the skills required to develop integrated research on cancer, covering a large scale from exploratory research to clinical research, including expertise fields such as biology, imaging, epidemiology, biostatistics, data science, social and human sciences, and health economics.